KEN OKAZAKI
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position   Professor and Division head
Article types Original article
Language English
Peer review Peer reviewed
Title Minimum 10-year results of cementless total hip arthroplasty in patients with rheumatoid arthritis.
Journal Formal name：Modern rheumatology
Abbreviation：Mod Rheumatol
ISSN code：14397609/14397595
Domestic / ForeginForegin
Volume, Issue, Page 27(4),pp.598-604
Author and coauthor Haraguchi Akihisa, Nakashima Yasuharu, Miyahara Hisaaki, Esaki Yukio, Okazaki Ken, Fukushi Jun-Ichi, Hirata Go, Ikemura Satoshi, Kamura Satoshi, Sakuraba Koji, Fujimura Kenjiro, Akasaki Yukio, Yamada Hisakata
Publication date 2017/07
Summary OBJECTIVES:To retrospectively evaluate the long-term results of cementless total hip arthroplasty (THA) in patients with rheumatoid arthritis (RA) and postoperative patient mortality after THA.METHODS:This study included 191 hips in 149 RA patients who underwent cementless THA between 1998 and 2005. Mean age at surgery was 54.2 years, and mean follow-up was 12.6 years. Implant and patient survivorships were determined using the Kaplan-Meier method, and the associated influencing factors were determined.RESULTS:Implant survivals at 17 years were 99.5% for stems, 93.9% for cups, and 90.8% for liners. Among the liners used, THAs with highly cross-linked polyethylene showed better survivals compared with those with conventional polyethylene and alumina-bearing surface (93.4%, 90.9%, and 52.2%, respectively). A total of 64 deaths occurred; 45 patients died within 10 years and 19 patients died between 10 and 17 years. Malignancy (25.0%) was the leading cause of death, followed by pneumonia (20.8%) and sepsis (20.8%). The patient survival rate was 36.9% at 17 years after THA. Multivariate analysis exhibited that older age at operation and greater dose of concomitant corticosteroid resulted in shorter patient survivals.CONCLUSIONS:Cementless THA worked well in patients with RA. Mortality remained high among RA patients who needed THA.
DOI 10.1080/14397595.2016.1256024
PMID 27846746